Usha Bio-Tech Limited, a struck off public limited company, was established on 16 November 2000 in Hyderabad, Telangana, India. Engaging in hospital services within the hospital and medical care sector, it holds CIN: U01122TG2000PLC035689. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.57 Cr.
It upholds a active non-compliant status. Its leadership includes Radhika Nadimpalli (Director), Venkata Subba Raju Kunaparaju (Director), Raj Kumar Kunaparaju (Managing Director). Past directors included Kunaparaju Kanaka Raju. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at F8, Mn I-Hub, Synergy Square 1 Genome Vallet, Turkapally, Shamirpet,, Hyderabad, Telangana, 500078.
U01122TG2000PLC035689
035689
16 November 2000
₹3.00 Cr
₹2.57 Cr
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Usha Bio-Tech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Radhika Nadimpalli | Director | 25 May 2010 | Current |
| Venkata Subba Raju Kunaparaju | Director | 25 May 2010 | Current |
| Raj Kumar Kunaparaju | Managing Director | 17 Jan 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jul 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Usha Bio-Tech Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 50.11% increase. The company also saw a substantial improvement in profitability, with a 1161.45% increase in profit. The company's net worth moved up by a moderate rise of 3.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Usha Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Usha Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Usha Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usha Bio-Tech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Usha Bio-Tech Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was recorded as a recent event.
Progress on Usha Bio-Tech Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was documented.
Radhika Nadimpalli was appointed as a Director was appointed as a Director on 25 May 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.
The activity Venkata Subba Raju Kunaparaju was appointed as a Director was appointed as a Director on 25 May 2010 & has been associated with this company since 15 years 6 months . was completed.
Progress on Raj Kumar Kunaparaju was appointed as a Managing Director was appointed as a Managing Director on 17 Jan 2005 & has been associated with this company since 20 years 11 months . was documented.
Usha Bio-Tech Limited was registered on 16 Nov 2000 with Roc Hyderabad & aged 25 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Usha Bio-Tech Limited is U01122TG2000PLC035689.
Usha Bio-Tech Limited is headquartered at F8, Mn I-Hub, Synergy Square 1 Genome Vallet, Turkapally, Shamirpet,, Hyderabad, Telangana, 500078.
Usha Bio-Tech Limited was incorporated on 16 November 2000.
The current directors of Usha Bio-Tech Limited are
The primary industry of Usha Bio-Tech Limited is Hospital And Medical Care.
Usha Bio-Tech Limited is unlisted.
The authorized capital of Usha Bio-Tech Limited is ₹3.00 Cr, and the paid-up capital is ₹2.57 Cr.
The compliance status of Usha Bio-Tech Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX